Current Eye Research · 2011 · 39 citations · 20 references
Life SciencesBiochemistryCell BiologyApoptosisCellular MetabolismOcular PharmacologyAntioxidant DefenseEndothelial DysfunctionGlutathione MetabolismOxidative StressOxidative Stress MechanismsReactive Oxygen SpeciesCell CountingCell Viability AssaysCellular Oxidative Stress ResponseCellular Response To Oxidative StressCorneal Endothelial Cell CultureOxidative Stress InjuryOxidative Stress-induced Cell DeathReduced Glutathione
PURPOSE: To investigate the protective effect of rapamycin on oxidative stress-induced cell death of human corneal endothelial cells (HCECs). METHODS: HCECs were cultured according to previously published methods. With treatment of 0 mM or 5 mM of tert-butyl hydroperoxide (tBHP) with various concentrations (0, 25 and 50 nM) of rapamycin, reactive oxygen species (ROS) production was measured using an oxidation-sensitive fluorescent probe, 2'7'-dichlorofluorescin diacetate (DCFH-DA, USA) methods. Cell viability was assayed by the method of Cell Counting Kit-8 (CCK-8, Wako). The levels of cellular glutathione were also assessed enzymatically with glutathione reductase by using a commercial glutathione (GSH) assay kit (Cayman Chemical, USA). RESULTS: Rapamycin reduced 2'7'-dihydrodichlorofluorescein oxidation and increased GSH in HCECs. Rapamycin significantly inhibited tBHP-induced ROS production. Cells treated with rapamycin showed higher viability compared to control at 5 mM tBHP. Rapamycin effectively protected HCECs from ROS-induced cell death through increasing intracellular GSH. CONCLUSION: Our data suggest that rapamycin protects HCECs from oxidative injury-mediated cell death via inhibition of ROS production and enhancement of GSH.
20
The structure and transparency of the cornea
D.M. Maurice · The Journal of Physiology · 1957 · 1.1K citations · Full text
Medicine, Anatomy, Ophthalmology +10
Munetaka Ishiyama, Hideyuki Tominaga, Masanobu Shiga et al. · Biological and Pharmaceutical Bulletin · 1996 · 733 citations · Full text